Cantara Silvia, Marzocchi Carlotta, Pilli Tania, Cardinale Sandro, Forleo Raffaella, Castagna Maria Grazia, Pacini Furio
Department of Medical, Surgical and Neurological Sciences, University of Siena, 53100 Siena, Italy.
Int J Mol Sci. 2017 Apr 6;18(4):775. doi: 10.3390/ijms18040775.
Fine needle aspiration cytology (FNAC) represents the gold standard for determining the nature of thyroid nodules. It is a reliable method with good sensitivity and specificity. However, indeterminate lesions remain a diagnostic challenge and researchers have contributed molecular markers to search for in cytological material to refine FNAC diagnosis and avoid unnecessary surgeries. Nowadays, several "home-made" methods as well as commercial tests are available to investigate the molecular signature of an aspirate. Moreover, other markers (i.e., microRNA, and circulating tumor cells) have been proposed to discriminate benign from malignant thyroid lesions. Here, we review the literature and provide data from our laboratory on mutational analysis of FNAC material and circulating microRNA expression obtained in the last 6 years.
细针穿刺细胞学检查(FNAC)是确定甲状腺结节性质的金标准。它是一种可靠的方法,具有良好的敏感性和特异性。然而,不确定病变仍然是一个诊断挑战,研究人员一直在寻找细胞学材料中的分子标志物,以完善FNAC诊断并避免不必要的手术。如今,有几种“自制”方法以及商业检测可用于研究抽吸物的分子特征。此外,还提出了其他标志物(即微小RNA和循环肿瘤细胞)来区分甲状腺良性和恶性病变。在此,我们回顾了文献,并提供了我们实验室过去6年中获得的关于FNAC材料突变分析和循环微小RNA表达的数据。